Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
29,807,413
-
Share change
-
+8,170,836
-
Total reported value
-
$3,248,633,999
-
Put/Call ratio
-
129%
-
Price per share
-
$109.19
-
Number of holders
-
214
-
Value change
-
+$932,698,420
-
Number of buys
-
127
-
Number of sells
-
81
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q1 2021
As of 31 Mar 2021,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
214 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,807,413 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Artisan Partners Limited Partnership, Bill & Melinda Gates Foundation, Artal Group S.A., BlackRock Inc., Temasek Holdings (Private) Ltd, and DekaBank Deutsche Girozentrale.
This page lists
218
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.